Medicine News and Research

RSS

Postmenopausal women receiving estrogen plus progestin at increased risk of breast cancer

Researchers have identified how the hormones progesterone and estrogen interact to increase cell growth in normal mammary cells and mammary cancers, a novel finding that may explain why postmenopausal women receiving hormone replacement therapy with estrogen plus progestin are at increased risk of breast cancer.

19 Jan 2011

Time-lapse technique can show cellular-level changes within deep brain regions: Study

Changes within deep regions of the brain can now be visualized at the cellular level, based on research on mice, which was funded by the National Institutes of Health. Published Sunday in Nature Medicine, the study used a groundbreaking technique to explore cellular-level changes over a period of weeks within deep brain regions, providing a level of detail not possible with previously available methods.

19 Jan 2011

UMMS begins MBL-HCV1 Phase 2 trial to prevent hepatitis C virus infection in liver transplant patients

Following a successful Phase 1 study for safety, researchers at MassBiologics of the University of Massachusetts Medical School today announced the beginning of a Phase 2 clinical trial testing the ability of a human monoclonal antibody they developed to prevent hepatitis C virus infection of a donor liver in transplant patients.

19 Jan 2011

Study shows new cardio-pulmonary resuscitation technique increases long-term survival of patients

A study led by Dr. Tom P. Aufderheide, professor of emergency medicine at The Medical College of Wisconsin, shows an alternative method of cardio-pulmonary resuscitation increases long-term survival of patients.

19 Jan 2011

Antidepressant medication reduces frequency and severity of menopausal hot flashes

Women who were either in the transition to menopause or postmenopausal experienced a reduction in the frequency and severity of menopausal hot flashes with the use of the antidepressant medication escitalopram, compared to women who received placebo, according to a study in the January 19 issue of JAMA.

19 Jan 2011

Severe asthma in early childhood may lead to premature loss of lung function during adolescence: Study

Severe asthma in early childhood may lead to premature loss of lung function during adolescence and more serious disease during adulthood, researchers at Emory University School of Medicine report. Early identification and treatment of children with severe asthma is important to help stem asthma progression.

19 Jan 2011

Modifiable and non-modifiable lifestyle factors influence breast cancer risk

Many risk factors for breast cancer are well studied and documented. Thus, scientists are sure by now that early first menstrual period, late onset of menopause and a family history of breast cancer are associated with an increased breast cancer risk.

19 Jan 2011

Diabetes increases risk of death in breast cancer patients

Breast cancer patients are nearly 50 percent more likely to die of any cause if they also have diabetes, according to a comprehensive review of research conducted by Johns Hopkins physicians.

18 Jan 2011

PAM50 test is now available to classify breast cancer subtypes

ARUP Laboratories, a leading national clinical and anatomic pathology reference laboratory and a leader in innovative laboratory research and development, today announced the availability of a new laboratory developed test designed to classify breast cancer into clinically significant molecular subtypes that are important for the management of the disease.

18 Jan 2011

Organic milk best: Study

The latest research published by Newcastle University, UK has shown that organic milk contains less unhealthy fat, as well as a range of important healthy nutrients. It contains fewer chemicals and poses less risk for children to develop allergies and eczema. Organic milk is also rich in omega 3 fatty acids that re good for the heart. However it costs more. At least 60 per cent of the diet of organic cows has to be organically grown grass and its traditional derivatives — silage and hay.

18 Jan 2011

GE Healthcare becomes US distributor and reseller of Veran's ig4 navigation system

GE Healthcare and Veran, a provider of proprietary 4D registration capability for precise targeting of lesions via its FDA cleared platform, today announced a strategic supplier agreement in which GE Healthcare becomes the exclusive distributor and reseller of Veran's ig4 navigation system in the United States.

18 Jan 2011

IntegraMed acquires Northwest Center for Reproductive Sciences

IntegraMed America, Inc., the leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, announced today that is has acquired Northwest Center for Reproductive Sciences (NCRS).

18 Jan 2011

Viewpoints: Next step after health law repeal effort; Refuting 'job-killing' claims; Mental health care

The continuing resolution that extended funding for the federal government until Mar. 4 gives us an opportunity to include language in the appropriations that fund the rest of this fiscal year — and must be passed to avoid a government shutdown. The language would prohibit any funds from being used to implement or enforce Obamacare (Rep. Steve King, 1/18).

18 Jan 2011

Harbor Biosciences signs development agreements for HE2000, HE3235 and HE3286 with CIPI

Harbor BioSciences, Inc., a leader in the development of a proprietary class of adrenal steroid hormones as novel pharmaceuticals, announced it has licensed the research and development and commercialization rights for three of its products, exclusively in the People's Republic of China and Hong Kong, to China State Institute of Pharmaceutical Industry (CIPI).

18 Jan 2011

New data on role of miR-34 tumor suppressor in preventing cancer stem cell development

Mirna Therapeutics, Inc., a leading developer of microRNA (miRNA)-based therapeutics, announced today the publication of new data in the journal Nature Medicine describing the role of the tumor suppressor miRNA, miR-34, in preventing cancer stem cell development. The published results reveal that miR-34 is commonly down-regulated in prostate cancer stem cells and that this down-regulation is essential for cancer stem cell viability.

18 Jan 2011

First Edition: January 18, 2011

Today's headlines feature reports about the upcoming repeal vote in the House as well as news about a government report that attempts to quantify the number of Americans who have preexisting conditions.

18 Jan 2011

Quebec reimburses VIDAZA for treatment of blood cancer

Quebec patients with serious blood cancers (intermediate-2 and high-risk myelodysplastic syndrome and acute myeloid leukemia) now have publicly funded access to a new innovative therapy, VIDAZA® (azacitidine). Following a priority review and subsequent positive recommendation from the Conseil du medicament, patients now have the potential to significantly extend survival.

18 Jan 2011

Hamilton Academy of Medicine launches campaign to increase awareness about smoking cessation

In honour of National Non-Smoking Week, The Hamilton Academy of Medicine is proud to introduce, It's Hamilton's Time to Quit, a campaign designed to increase awareness about local quitting resources and tools to help the community understand the support that is available, and encourage people to seek the assistance they need to stop smoking.

18 Jan 2011

Women's Health Congress to explore mammography controversy

The ongoing controversy about the appropriate age, frequency, and patient benefit of mammography will be explored at the upcoming 19th Annual Congress on Women's Health, April 1-3, 2011 in Washington DC.

18 Jan 2011

New guideline recommends plasmapheresis usage to treat people with severe relapses in MS, neuropathies

A new guideline from the American Academy of Neurology recommends using plasma exchange to treat people with severe relapses in multiple sclerosis and related diseases, as well as those with certain kinds of nerve disorders known as neuropathies.

18 Jan 2011

Medicine News and Research

Postmenopausal women receiving estrogen plus progestin at increased risk of breast cancer

Time-lapse technique can show cellular-level changes within deep brain regions: Study

UMMS begins MBL-HCV1 Phase 2 trial to prevent hepatitis C virus infection in liver transplant patients

Study shows new cardio-pulmonary resuscitation technique increases long-term survival of patients

Antidepressant medication reduces frequency and severity of menopausal hot flashes

Severe asthma in early childhood may lead to premature loss of lung function during adolescence: Study

Modifiable and non-modifiable lifestyle factors influence breast cancer risk

Diabetes increases risk of death in breast cancer patients

PAM50 test is now available to classify breast cancer subtypes

Organic milk best: Study

GE Healthcare becomes US distributor and reseller of Veran's ig4 navigation system

IntegraMed acquires Northwest Center for Reproductive Sciences

Viewpoints: Next step after health law repeal effort; Refuting 'job-killing' claims; Mental health care

Harbor Biosciences signs development agreements for HE2000, HE3235 and HE3286 with CIPI

New data on role of miR-34 tumor suppressor in preventing cancer stem cell development

First Edition: January 18, 2011

Quebec reimburses VIDAZA for treatment of blood cancer

Hamilton Academy of Medicine launches campaign to increase awareness about smoking cessation

Women's Health Congress to explore mammography controversy

New guideline recommends plasmapheresis usage to treat people with severe relapses in MS, neuropathies

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News